Skip to content

Clinical trials

Fabry Disease trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Country / region: United Kingdom Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20041
20063
20071
20083
20092
20102
20112
20121
20131
20143
20153
20161
20172
20185
20195
20201
20211
20224
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Active, not recruiting6
Recruiting6
Terminated6
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amicus Therapeutics11
Genzyme, a Sanofi Company10
Chiesi Farmaceutici S.p.A.6
Protalix5
CENTOGENE GmbH Rostock2
Idorsia Pharmaceuticals Ltd.2
Manchester University NHS Foundation Trust2
Sangamo Therapeutics2
Sanofi2
Shire2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease51
Lysosomal Storage Diseases5
Proteinuria3
Angiokeratoma1
Atypical Hemolytic Uremic Syndrome1
Bartter Syndrome1
Calciphylaxis1
Cardiomyopathies1
Cystinosis1
Cystinuria1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.